Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
RecruitingNCT05909761
AmgenNeuromyelitis Optica Spectrum Disorder, Pregnancy Related
Start: 2026-10-15End: 2032-10-31Target: 60Updated: 2026-08-31